Patent ID: 7833976

Claim:
A method for treating a tumor cell in a patient comprising administering to said patient a tumor cell proliferation inhibiting amount of: a) an angiogenesis inhibiting agent; and b) an anti-tumor immunotherapeutic agent comprising a cell-effector component and a tumor associated antigen targeting component; wherein the cell-effector component is a chemokine selected from the group consisting of C10, EMF-1, ENA-78, Eotaxin, GCP-2, HCC-1, I-309, IL-8, IP-10, Lymphotactin, MCP-1, MCP-2, MCP-3, MGSA, MIG, MIP-1alpha, MIP-1beta, MIP-2, NAP-2, PF4, RANTES, SCM-1, and SDF-1.